[ Price : $8.95]
FDA approves Janssen Biotechs Darzalex (daratumumab) in combination with Amgens Kyprolis (carfilzomib) and dexamethasone for relap...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance on bioavailability and bioequivalence samples retention.[ Price : $8.95]
Federal Register notice: FDA issues a stay of effectiveness provisions for electrical stimulation devices for use on certain self-...[ Price : $8.95]
Some dietary supplement manufacturers are concerned that FDA may be cracking down on products that include N-acetylcysteine, which...[ Price : $8.95]
FDA warns Predictive Biotech that it is marketing an unapproved and misbranded umbilical cord-derived product as a Covid-19 treatm...[ Price : $8.95]
Federal Register notice: FDA clarifies that an executive summary of a public meeting on Testing Methods for Asbestos in Talc and C...[ Price : $8.95]
FDA holds up an emergency use authorization for using blood plasma therapy for treating Covid-19 patients until more data is prese...[ Price : $8.95]
FDA issues a complete response letter to Gilead for its filgotinib to treat rheumatoid arthritis, seeking information from two stu...